Related Experiment Video

Updated: Aug 8, 2026

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay
06:29

Accurate and Simple Measurement of the Pro-inflammatory Cytokine IL-1β using a Whole Blood Stimulation Assay

Published on: March 2, 2011

The two interleukin-1 receptors play different roles in IL-1 actions

J E Sims1, J G Giri, S K Dower

  • 1Immunex Research and Development Corporation, Seattle, Washington 98101.

Clinical Immunology and Immunopathology
|July 1, 1994
PubMed

Insights

Interleukin-1 (IL-1) signals through type I receptors. Type II receptors act as negative regulators by binding IL-1, preventing signaling, and can be soluble inhibitors of IL-1 action.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Interleukin-1 (IL-1) is a key proinflammatory cytokine.
  • IL-1 exerts its biological effects through cell-surface receptors.
  • Two distinct receptors, type I and type II, have been identified for IL-1.

Purpose of the Study:

  • To elucidate the distinct roles of IL-1 type I and type II receptors.
  • To investigate the inhibitory potential of soluble forms of IL-1 receptors.
  • To assess the therapeutic efficacy of soluble IL-1 receptor type I.

Main Methods:

  • Biochemical characterization of type I and type II IL-1 receptors.
  • Analysis of IL-1 binding kinetics and signaling pathways.
  • Evaluation of soluble receptor activity in preclinical models and clinical trials.

Main Results:

  • Type I receptor (80 kDa) mediates IL-1 biological effects.
  • Type II receptor (60 kDa) binds IL-1, acting as a negative regulator without signaling.
  • Both soluble type II and recombinant soluble type I receptors inhibit IL-1 action.
  • Soluble type I receptor demonstrated efficacy in inflammatory disease models and a clinical allergy trial.

Conclusions:

  • The type II receptor functions as a natural inhibitor of IL-1 by sequestering the cytokine.
  • Soluble IL-1 receptors, particularly type I, represent a promising therapeutic strategy for inflammatory conditions.
  • Targeting IL-1 receptor interactions offers a viable approach for managing IL-1-mediated diseases.

More Related Videos

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells09:04

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells

Published on: May 22, 2014

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions08:40

An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions

Published on: March 14, 2016

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...